PGIM QMA Strategic Alpha Sm-Cp Val ETF (PQSV)

52.28 +0.14  +0.26% NYSE Arca Dec 11, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 52.31
Discount or Premium to NAV -0.06%
Turnover Ratio 66.00%
1 Year Fund Level Flows --
View All PQSV News

News

  • Wire
    Headline
    Time (ET)

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.93% 1.94% 0.41% 10
3M 3.95% 3.99% 5.08% 23
6M 10.20% 10.13% 7.80% 18
YTD 19.92% 19.87% 18.36% 37
1Y 12.87% 13.19% 11.10% 33
3Y -- -- 2.11% --
5Y -- -- 5.59% --
10Y -- -- 10.01% --
15Y -- -- 6.80% --
20Y -- -- 9.48% --
As of Dec. 11, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.64% 2.16% 1.52%
Stock 99.36% 99.36% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 11, 2019

Region Exposure

Americas 99.41%
North America 98.87%
Latin America 0.54%
Greater Europe 0.34%
United Kingdom 0.00%
Europe Developed 0.34%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.24%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.12%
Asia Emerging 0.13%
Market Classification
% Developed Markets 99.74%
% Emerging Markets 0.26%
As of Dec. 10, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 5.06%
Communication Services 3.34%
Consumer Cyclical 11.75%
Consumer Defensive 3.43%
Energy 5.23%
Financial Services 30.48%
Healthcare 6.50%
Industrials 15.59%
Real Estate 9.72%
Technology 6.46%
Utilities 2.44%
As of Dec. 11, 2019

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 2.69%
Small 47.09%
Micro 50.21%
As of Dec. 11, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.66%
Mid Cap Blend 1.80%
Mid Cap Growth 0.41%
Small Cap Value 43.92%
Small Cap Blend 40.99%
Small Cap Growth 12.21%
As of Dec. 11, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
MRSN Mersana Therapeutics Inc 0.31% 3.82 -2.80%
EROS Eros International PLC 0.28% 3.24 -0.31%
BREW Craft Brew Alliance Inc 0.24% 16.45 -0.30%
MR Montage Resources Corp 0.24% 6.75 +4.01%
SGRY Surgery Partners Inc 0.24% 14.66 -1.11%
EXPR Express, Inc. 0.23% 5.63 +1.44%
ABEO Abeona Therapeutics Inc 0.22% 3.99 -0.75%
PRTA Prothena Corp PLC 0.20% 12.98 +3.84%
TPCO Tribune Publishing Co 0.19% 12.59 -1.60%
AKBA Akebia Therapeutics Inc 0.19% 6.35 +1.11%
As of Dec. 11, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term growth of capital. The fund's goal is to outperform the returns of the Russell 2000 Value Index over the long term. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of U.S. small-capitalization companies. The term "investable assets" refers to the fund's net assets plus any borrowings for investment purposes. It is an actively managed ETF and, thus, does not seek to replicate the performance of a specified index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Value
Prospectus Objective Small Company
Fund Owner Firm Name PGIM Funds (Prudential)
Reports
One Page Report Download

Manager Info

Name Tenure
Edward Lithgow 0.97 yrs
Stephen Courtney 0.97 yrs

Net Fund Flows

1M 0.00
3M 0.00
6M 0.00
YTD 0.00
1Y --
3Y --
5Y --
10Y --
As of Nov. 30, 2019

Risk Info

Beta (5Y) --
Max Drawdown (All) 14.58%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.5076
30-Day Rolling Volatility 11.65%
Daily Value at Risk (VaR) 1% (All) 3.20%
Monthly Value at Risk (VaR) 1% (All) 13.41%

Fundamentals

Dividend Yield TTM (12-11-19) 1.66%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 12.83
Weighted Average Price to Sales Ratio 0.6633
Weighted Average Price to Book Ratio 1.129
Weighted Median ROE 5.22%
Weighted Median ROA 1.49%
Forecasted Dividend Yield 2.28%
Forecasted PE Ratio 11.69
Forecasted Price to Sales Ratio 0.6361
Forecasted Price to Book Ratio 1.073
Number of Holdings 761
As of Dec. 10, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.82%
Forecasted Book Value Growth -2.24%
Forecasted Cash Flow Growth -8.19%
Forecasted Earnings Growth 7.21%
Forecasted Revenue Growth -6.44%
As of Dec. 10, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 11/13/2018
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 10/29/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.